WASHINGTON – With robust public participation over the course of 17 prior events, the National Prescription Drug Take Back Day Initiative continues to remove ever-higher amounts of opioids and other medicines from the nation’s homes, where they are vulnerable to misuse, theft or abuse by family members and visitors, including...

GULFPORT, Miss. – The Drug Enforcement Administration announced David Quevedo Martinez, 40, of Houston, Texas, was sentenced yesterday by a senior U.S. district judge to life in federal prison for conspiring to possess with intent to distribute 500 grams or more of methamphetamine. Martinez was also ordered to pay a...

HUNTSVILLE, Ala. – A joint federal, state, and local law enforcement initiative has resulted in the arrests of 36 individuals on a variety of criminal charges, including drug trafficking, money laundering, using communication facilities to facilitate drug trafficking and various firearms offenses, announced the Drug Enforcement Administration. The majority of...

WASHINGTON – First Lady Melania Trump today joined DEA Acting Administrator Uttam Dhillon to celebrate the official launch of the 2019 Red Ribbon campaign, dedicated to preserving the memory of DEA Special Agent Enrique “Kiki” Camarena – a DEA special agent who was kidnapped, tortured, and murdered in Mexico by...

WASHINGTON – The U.S. Drug Enforcement Administration and the U.S. Food and Drug Administration have issued warning letters to four website owners of rogue online pharmacies offering to distribute or dispense controlled substances, including opioids, and advertising their sale in violation of federal law. This is the first time the...

BIRMINGHAM, Ala. – A delegation of law enforcement members from the state of Alabama, to include representatives from the Drug Enforcement Administration, recently returned from a covert trip to Mexico and to the state of Sinaloa, home of the Sinaloa Cartel, announced DEA Assistant Special Agent in Charge Clay Morris...

WASHINGTON – In an effort to reduce the availability of deadly illegal fentanyl in America, the U.S. Drug Enforcement Administration has proposed to control three substances used by operators of clandestine laboratories to illicitly manufacture the deadly Schedule II controlled substance. Two Notices of Proposed Rulemaking were published in the...

WASHINGTON – The U.S. Drug Enforcement Administration is proposing to reduce the amount of five Schedule II opioid controlled substances that can be manufactured in the United States next year compared with 2019, per the Notice of Proposed Rulemaking being published in the Federal Register tomorrow and available for public...

WASHINGTON – The Drug Enforcement Administration today announced that it is moving forward to facilitate and expand scientific and medical research for marijuana in the United States. The DEA is providing notice of pending applications from entities applying to be registered to manufacture marijuana for researchers. DEA anticipates that registering...

WASHINGTON – The operator of a network of businesses in Lebanon and Africa, whom the United States Department of the Treasury designated as a financier of Lebanon-based terrorist group Hezbollah, was sentenced to five years in prison and ordered to forfeit $50 million by U.S. District Judge Reggie B. Walton...